AbbVie (NYSE:ABBV) Price Target Increased to $170.00 by Analysts at Piper Jaffray Companies

AbbVie (NYSE:ABBV – Free Report) had its price target raised by Piper Jaffray Companies from $163.00 to $170.00 in a report released on Friday, Stock Target Advisor reports. Piper Jaffray Companies currently has an overweight rating on the stock. ABBV has been the subject of several other research reports. StockNews.com assumed coverage on shares of […]

Related Keywords

William Blair ,Venclexta Venclyxto ,Piper Jaffray Companies ,Compass Wealth Management ,Morgan Stanley ,Abbvie Inc ,Lindbrook Capital ,Johnson White Wealth Management ,Free Report ,Stock Target Advisor ,Jaffray Companies ,Moderate Buy ,Get Free Report ,White Wealth Management ,Wealth Management ,Michigan Retirement System ,Vie Inc ,Abbvie Daily ,Abbvie ,Nyse Abbv ,Abbv ,Medical ,00287y10 ,Boost Price Target ,